In addition, disease-free survival and overall survival of lung adenocarcinoma patients with high CEBPB expression were significantly decreased (p = 0.0065 and p = 0.032, respectively) (Fig. 1I). The gene discussed is CEBPB; the disease is lung adenocarcinoma.